TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9366076
log Bayes Factor = 10.6744
Chromosome 6   position 167,373,708  (GRCh37) Explore rs9366076 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.007 0.993
E00-E07 Disorders of thyroid gland
0.000 0.015 0.985
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.027 0.973
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.041 0.959
E07 Other disorders of thyroid
0.000 0.064 0.936
E07.9 Disorder of thyroid, unspecified
0.000 0.110 0.890
E06 Thyroiditis
0.000 0.117 0.883
E03.8 Other specified hypothyroidism
0.000 0.156 0.844
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.184 0.816
E06.3 Autoimmune thyroiditis
0.000 0.221 0.779
E05.9 Thyrotoxicosis, unspecified
0.000 0.224 0.776
E07.8 Other specified disorders of thyroid
0.000 0.264 0.736
E03.5 Myxoedema coma
0.000 0.288 0.712
E03.4 Atrophy of thyroid (acquired)
0.000 0.288 0.712
E03.3 Postinfectious hypothyroidism
0.000 0.288 0.712
E03.1 Congenital hypothyroidism without goitre
0.000 0.288 0.712
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.293 0.706
E00 Congenital iodine-deficiency syndrome
0.000 0.293 0.706
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.293 0.706
E06.9 Thyroiditis, unspecified
0.000 0.294 0.706
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.300 0.700
E05.5 Thyroid crisis or storm
0.000 0.303 0.697
E05.4 Thyrotoxicosis factitia
0.000 0.303 0.697
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.303 0.697
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.303 0.697
E07.1 Dyshormogenetic goitre
0.000 0.329 0.671
E07.0 Hypersecretion of calcitonin
0.000 0.329 0.671
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.366 0.634
E06.5 Other chronic thyroiditis
0.000 0.367 0.633
E06.4 Drug-induced thyroiditis
0.000 0.367 0.633
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.367 0.633
E06.1 Subacute thyroiditis
0.000 0.367 0.633
E06.0 Acute thyroiditis
0.000 0.367 0.633
E05.8 Other thyrotoxicosis
0.000 0.492 0.507
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.493 0.506
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.493 0.506
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.493 0.506
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.493 0.506
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.493 0.506
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.493 0.506
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.493 0.506
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.493 0.506
E04 Other non-toxic goitre
0.000 0.587 0.413
E04.0 Non-toxic diffuse goitre
0.000 0.649 0.351
E04.8 Other specified non-toxic goitre
0.000 0.704 0.296
E04.1 Non-toxic single thyroid nodule
0.000 0.766 0.234
E04.9 Non-toxic goitre, unspecified
0.000 0.823 0.177
E04.2 Non-toxic multinodular goitre
0.000 0.838 0.162
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.874 0.126
E50-E64 Other nutritional deficiencies
0.000 0.888 0.111
E14.9 Without complications
0.000 0.892 0.108
E10-E14 Diabetes mellitus
0.000 0.893 0.107
E14 Unspecified diabetes mellitus
0.000 0.894 0.106
E53 Deficiency of other B group vitamins
0.000 0.897 0.103
E53.8 Deficiency of other specified B group vitamins
0.000 0.905 0.095
E61 Deficiency of other nutrient elements
0.000 0.908 0.092
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.909 0.091
E14.4 With neurological complications
0.000 0.911 0.089
E53.9 Vitamin B deficiency, unspecified
0.000 0.917 0.083
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.920 0.080
E63 Other nutritional deficiencies
0.000 0.920 0.080
E56 Other vitamin deficiencies
0.000 0.920 0.080
E51 Thiamine deficiency
0.000 0.920 0.080
E50 Vitamin A deficiency
0.000 0.920 0.080
E60 Dietary zinc deficiency
0.000 0.920 0.080
E59 Dietary selenium deficiency
0.000 0.920 0.080
E58 Dietary calcium deficiency
0.000 0.920 0.080
E54 Ascorbic acid deficiency
0.000 0.920 0.080
E52 Niacin deficiency [pellagra]
0.000 0.920 0.080
E40-E46 Malnutrition
0.000 0.923 0.077
E12 Malnutrition-related diabetes mellitus
0.000 0.923 0.077
E14.7 With multiple complications
0.000 0.924 0.076
E14.2 Withrenal complications
0.000 0.924 0.076
E14.0 With coma
0.000 0.924 0.076
E10 Insulin-dependent diabetes mellitus
0.000 0.925 0.075
E53.1 Pyridoxine deficiency
0.000 0.926 0.074
E53.0 Riboflavin deficiency
0.000 0.926 0.074
E14.1 With ketoacidosis
0.000 0.926 0.074
E14.5 With peripheral circulatory complications
0.000 0.926 0.073
E61.1 Iron deficiency
0.000 0.927 0.073
E61.2 Magnesium deficiency
0.000 0.927 0.072
E14.8 With unspecified complications
0.000 0.927 0.072
E14.3 With ophthalmic complications
0.000 0.928 0.072
E10.4 With neurological complications
0.000 0.931 0.069
E61.9 Deficiency of nutrient element, unspecified
0.000 0.934 0.066
E61.8 Deficiency of other specified nutrient elements
0.000 0.934 0.066
E61.7 Deficiency of multiple nutrient elements
0.000 0.934 0.066
E61.6 Vanadium deficiency
0.000 0.934 0.066
E61.5 Molybdenum deficiency
0.000 0.934 0.066
E61.4 Chromium deficiency
0.000 0.934 0.066
E61.3 Manganese deficiency
0.000 0.934 0.066
E61.0 Copper deficiency
0.000 0.934 0.066
E16 Other disorders of pancreatic internal secretion
0.000 0.935 0.065
E15 Nondiabetic hypoglycaemic coma
0.000 0.935 0.065
E13 Other specified diabetes mellitus
0.000 0.937 0.063
E14.6 With other specified complications
0.000 0.938 0.062
E10.0 With coma
0.000 0.939 0.061
E10.1 With ketoacidosis
0.000 0.939 0.061
E50.9 Vitamin A deficiency, unspecified
0.000 0.942 0.058
E50.8 Other manifestations of vitamin A deficiency
0.000 0.942 0.058
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.942 0.058
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.942 0.058
E50.5 Vitamin A deficiency with night blindness
0.000 0.942 0.058
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.942 0.058
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.942 0.058
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.942 0.058
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.942 0.058
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.942 0.058
E51.9 Thiamine deficiency, unspecified
0.000 0.942 0.058
E51.8 Other manifestations of thiamine deficiency
0.000 0.942 0.058
E51.2 Wernicke's encephalopathy
0.000 0.942 0.058
E51.1 Beriberi
0.000 0.942 0.058
E56.9 Vitamin deficiency, unspecified
0.000 0.942 0.058
E56.8 Deficiency of other vitamins
0.000 0.942 0.058
E56.1 Deficiency of vitamin K
0.000 0.942 0.058
E56.0 Deficiency of vitamin E
0.000 0.942 0.058
E63.9 Nutritional deficiency, unspecified
0.000 0.942 0.058
E63.8 Other specified nutritional deficiencies
0.000 0.942 0.058
E63.1 Imbalance of constituents of food intake
0.000 0.942 0.058
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.942 0.058
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.942 0.058
E64.8 Sequelae of other nutritional deficiencies
0.000 0.942 0.058
E64.3 Sequelae of rickets
0.000 0.942 0.058
E64.2 Sequelae of vitamin C deficiency
0.000 0.942 0.058
E64.1 Sequelae of vitamin A deficiency
0.000 0.942 0.058
E64.0 Sequelae of protein-energy malnutrition
0.000 0.942 0.058
E10.2 With renal complications
0.000 0.943 0.057
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.944 0.055
E45 Retarded development following protein-energy malnutrition
0.000 0.944 0.055
E43 Unspecified severe protein-energy malnutrition
0.000 0.944 0.055
E42 Marasmic kwashiorkor
0.000 0.944 0.055
E41 Nutritional marasmus
0.000 0.944 0.055
E40 Kwashiorkor
0.000 0.944 0.055
E12.9 Without complications
0.000 0.945 0.055
E12.8 With unspecified complications
0.000 0.945 0.055
E12.7 With multiple complications
0.000 0.945 0.055
E12.6 With other specified complications
0.000 0.945 0.055
E12.5 With peripheral circulatory complications
0.000 0.945 0.055
E12.4 With neurological complications
0.000 0.945 0.055
E12.3 With ophthalmic complications
0.000 0.945 0.055
E12.2 With renal complications
0.000 0.945 0.055
E12.1 With ketoacidosis
0.000 0.945 0.055
E12.0 With coma
0.000 0.945 0.055
E10.7 With multiple complications
0.000 0.946 0.054
E10.8 With unspecified complications
0.000 0.946 0.054
E65-E68 Obesity and other hyperalimentation
0.000 0.946 0.054
E55 Vitamin D deficiency
0.000 0.949 0.051
E10.6 With other specified complications
0.000 0.949 0.051
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.951 0.049
E16.1 Other hypoglycaemia
0.000 0.952 0.048
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.953 0.047
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.953 0.047
E16.4 Abnormal secretion of gastrin
0.000 0.953 0.047
E16.3 Increased secretion of glucagon
0.000 0.953 0.047
E13.8 With unspecified complications
0.000 0.954 0.045
E13.7 With multiple complications
0.000 0.954 0.045
E13.6 With other specified complications
0.000 0.954 0.045
E13.5 With peripheral circulatory complications
0.000 0.954 0.045
E13.4 With neurological complications
0.000 0.954 0.045
E13.2 With renal complications
0.000 0.954 0.045
E13.1 With ketoacidosis
0.000 0.954 0.045
E13.0 With coma
0.000 0.954 0.045
E10.9 Without complications
0.000 0.955 0.045
E16.2 Hypoglycaemia, unspecified
0.000 0.956 0.044
C44.3 Skin of other and unspecified parts of face
0.044 0.956 0.000
E83.1 Disorders of iron metabolism
0.000 0.957 0.043
E46 Unspecified protein-energy malnutrition
0.000 0.958 0.042
E83 Disorders of mineral metabolism
0.000 0.959 0.041
E70-E90 Metabolic disorders
0.000 0.959 0.041
E13.9 Without complications
0.000 0.960 0.040
E44.1 Mild protein-energy malnutrition
0.000 0.960 0.040
E44.0 Moderate protein-energy malnutrition
0.000 0.960 0.040
E13.3 With ophthalmic complications
0.000 0.961 0.039
E67 Other hyperalimentation
0.000 0.961 0.039
E68 Sequelae of hyperalimentation
0.000 0.961 0.039
E10.5 With peripheral circulatory complications
0.000 0.961 0.038
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.962 0.038
E55.0 Rickets, active
0.000 0.963 0.037
N95.2 Postmenopausal atrophic vaginitis
0.037 0.963 0.000
E83.3 Disorders of phosphorus metabolism
0.000 0.964 0.036
E89.0 Postprocedural hypothyroidism
0.000 0.966 0.034
E88 Other metabolic disorders
0.000 0.966 0.034
E89.2 Postprocedural hypoparathyroidism
0.000 0.967 0.033
L43.9 Lichen planus, unspecified
0.000 0.968 0.032
E66 Obesity
0.000 0.969 0.031
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.970 0.030
E83.8 Other disorders of mineral metabolism
0.000 0.970 0.030
E83.2 Disorders of zinc metabolism
0.000 0.970 0.030
E83.0 Disorders of copper metabolism
0.000 0.970 0.030
E84 Cystic fibrosis
0.000 0.970 0.029
E79 Disorders of purine and pyrimidine metabolism
0.000 0.970 0.029
E77 Disorders of glycoprotein metabolism
0.000 0.970 0.029
E76 Disorders of glycosaminoglycan metabolism
0.000 0.970 0.029
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.970 0.029
E72 Other disorders of amino-acid metabolism
0.000 0.970 0.029
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.970 0.029
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.970 0.029
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.971 0.029
E67.8 Other specified hyperalimentation
0.000 0.972 0.028
E67.3 Hypervitaminosis D
0.000 0.972 0.028
E67.2 Megavitamin-B6 syndrome
0.000 0.972 0.028
E67.1 Hypercarotenaemia
0.000 0.972 0.028
E67.0 Hypervitaminosis A
0.000 0.972 0.028
E70 Disorders of aromatic amino-acid metabolism
0.000 0.972 0.027
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.973 0.027
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.973 0.027
E89.5 Postprocedural testicular hypofunction
0.000 0.973 0.027
E89.1 Postprocedural hypoinsulinaemia
0.000 0.973 0.027
E88.2 Lipomatosis, not elsewhere classified
0.000 0.973 0.027
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.973 0.027
C44 Other malignant neoplasms of skin
0.026 0.974 0.000
E89.4 Postprocedural ovarian failure
0.000 0.974 0.026
E89.3 Postprocedural hypopituitarism
0.000 0.974 0.026
E74 Other disorders of carbohydrate metabolism
0.000 0.974 0.025
E88.8 Other specified metabolic disorders
0.000 0.975 0.025
E88.9 Metabolic disorder, unspecified
0.000 0.975 0.024
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.975 0.024
C43.9 Malignant melanoma of skin, unspecified
0.024 0.976 0.000
C43 Malignant melanoma of skin
0.024 0.976 0.000
E66.8 Other obesity
0.000 0.976 0.024
C43-C44 Melanoma and other malignant neoplasms of skin
0.024 0.976 0.000
E73 Lactose intolerance
0.000 0.977 0.023
C44.6 Skin of upper limb, including shoulder
0.023 0.977 0.000
E66.1 Drug-induced obesity
0.000 0.978 0.022
C44.0 Skin of lip
0.022 0.978 0.000
C44.2 Skin of ear and external auricular canal
0.022 0.978 0.000
T78.1 Other adverse food reactions, not elsewhere classified
0.022 0.978 0.000
E71.3 Disorders of fatty-acid metabolism
0.000 0.978 0.021
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.978 0.021
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.978 0.021
E71.0 Maple-syrup-urine disease
0.000 0.978 0.021
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.978 0.021
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.978 0.021
E72.5 Disorders of glycine metabolism
0.000 0.978 0.021
E72.4 Disorders of ornithine metabolism
0.000 0.978 0.021
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.978 0.021
E72.2 Disorders of urea cycle metabolism
0.000 0.978 0.021
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.978 0.021
E72.0 Disorders of amino-acid transport
0.000 0.978 0.021
E75.6 Lipid storage disorder, unspecified
0.000 0.978 0.021
E75.5 Other lipid storage disorders
0.000 0.978 0.021
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.978 0.021
E75.3 Sphingolipidosis, unspecified
0.000 0.978 0.021
E75.2 Other sphingolipidosis
0.000 0.978 0.021
E75.1 Other gangliosidosis
0.000 0.978 0.021
E75.0 GM2 gangliosidosis
0.000 0.978 0.021
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.978 0.021
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.978 0.021
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.978 0.021
E76.2 Other mucopolysaccharidoses
0.000 0.978 0.021
E76.1 Mucopolysaccharidosis, type II
0.000 0.978 0.021
E76.0 Mucopolysaccharidosis, type I
0.000 0.978 0.021
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.978 0.021
E77.8 Other disorders of glycoprotein metabolism
0.000 0.978 0.021
E77.1 Defects in glycoprotein degradation
0.000 0.978 0.021
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.978 0.021
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.978 0.021
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.978 0.021
E79.1 Lesch-Nyhan syndrome
0.000 0.978 0.021
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.978 0.021
E84.9 Cystic fibrosis, unspecified
0.000 0.978 0.021
E84.8 Cystic fibrosis with other manifestations
0.000 0.978 0.021
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.978 0.021
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.978 0.021
E85 Amyloidosis
0.000 0.978 0.021
C43.5 Malignant melanoma of trunk
0.021 0.979 0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.979 0.021
E88.3 Tumour lysis syndrome
0.000 0.979 0.021
E65 Localised adiposity
0.001 0.980 0.020
C43.4 Malignant melanoma of scalp and neck
0.020 0.980 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.980 0.020
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.980 0.020
E70.2 Disorders of tyrosine metabolism
0.000 0.980 0.020
E70.1 Other hyperphenylalaninaemias
0.000 0.980 0.020
E70.0 Classical phenylketonuria
0.000 0.980 0.020
C43.1 Malignant melanoma of eyelid, including canthus
0.020 0.980 0.000
L43 Lichen planus
0.000 0.980 0.020
E66.0 Obesity due to excess calories
0.000 0.980 0.019
T78 Adverse effects, not elsewhere classified
0.020 0.980 0.000
E83.4 Disorders of magnesium metabolism
0.000 0.981 0.019
C44.8 Overlapping lesion of skin
0.019 0.981 0.000
N95 Menopausal and other perimenopausal disorders
0.019 0.981 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.019 0.981 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.981 0.018
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.981 0.018
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.981 0.018
E74.2 Disorders of galactose metabolism
0.000 0.981 0.018
E74.1 Disorders of fructose metabolism
0.000 0.981 0.018
E74.0 Glycogen storage disease
0.000 0.981 0.018
E83.5 Disorders of calcium metabolism
0.000 0.982 0.018
N95.3 States associated with artificial menopause
0.018 0.982 0.000
C44.9 Malignant neoplasm of skin, unspecified
0.018 0.982 0.000
E70.3 Albinism
0.000 0.982 0.018
C43.8 Overlapping malignant melanoma of skin
0.018 0.982 0.000
C43.0 Malignant melanoma of lip
0.018 0.982 0.000
O47.1 False labour at or after 37 completed weeks of gestation
0.018 0.982 0.000
T78.2 Anaphylactic shock, unspecified
0.017 0.983 0.000
N95.8 Other specified menopausal and perimenopausal disorders
0.017 0.983 0.000
L43.8 Other lichen planus
0.000 0.983 0.017
E73.8 Other lactose intolerance
0.000 0.983 0.016
E73.1 Secondary lactase deficiency
0.000 0.983 0.016
E73.0 Congenital lactase deficiency
0.000 0.983 0.016
E85.4 Organ-limited amyloidosis
0.000 0.984 0.016
T78.0 Anaphylactic shock due to adverse food reaction
0.016 0.984 0.000
D46.9 Myelodysplastic syndrome, unspecified
0.016 0.984 0.000
T78.4 Allergy, unspecified
0.016 0.984 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.016 0.984 0.000
E85.8 Other amyloidosis
0.000 0.984 0.015
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.984 0.015
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.984 0.015
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.984 0.015
N95.9 Menopausal and perimenopausal disorder, unspecified
0.016 0.984 0.000
T78.9 Adverse effect, unspecified
0.016 0.984 0.000
T78.8 Other adverse effects, not elsewhere classified
0.016 0.984 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.016 0.984 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.015 0.985 0.000
C44.5 Skin of trunk
0.015 0.985 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.985 0.015
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.015 0.985 0.000
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.985 0.014
L43.3 Subacute (active) lichen planus
0.000 0.986 0.014
L43.2 Lichenoid drug reaction
0.000 0.986 0.014
L43.1 Bullous lichen planus
0.000 0.986 0.014
L43.0 Hypertrophic lichen planus
0.000 0.986 0.014
C49.1 Connective and soft tissue of upper limb, including shoulder
0.014 0.986 0.000
D46 Myelodysplastic syndromes
0.014 0.986 0.000
C45 Mesothelioma
0.014 0.986 0.000
C49.0 Connective and soft tissue of head, face and neck
0.014 0.986 0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.987 0.013
E10.3 With ophthalmic complications
0.000 0.987 0.013
C48.2 Peritoneum, unspecified
0.013 0.987 0.000
E85.3 Secondary systemic amyloidosis
0.000 0.987 0.013
E78.2 Mixed hyperlipidaemia
0.000 0.987 0.013
C44.7 Skin of lower limb, including hip
0.013 0.987 0.000
C45.9 Mesothelioma, unspecified
0.013 0.987 0.000
C32.1 Supraglottis
0.013 0.987 0.000
C32 Malignant neoplasm of larynx
0.013 0.987 0.000
T78.3 Angioneurotic oedema
0.012 0.987 0.000
C49.3 Connective and soft tissue of thorax
0.012 0.988 0.000
C48.0 Retroperitoneum
0.012 0.988 0.000
C48.1 Specified parts of peritoneum
0.012 0.988 0.000
E86 Volume depletion
0.000 0.988 0.012
C43.6 Malignant melanoma of upper limb, including shoulder
0.012 0.988 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.012 0.988 0.000
C49.9 Connective and soft tissue, unspecified
0.012 0.988 0.000
C49.5 Connective and soft tissue of pelvis
0.012 0.988 0.000
C49.6 Connective and soft tissue of trunk, unspecified
0.011 0.988 0.000
C49.8 Overlapping lesion of connective and soft tissue
0.011 0.988 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.011 0.989 0.000
C46 Kaposi's sarcoma
0.011 0.989 0.000
D46.2 Refractory anaemia with excess of blasts
0.011 0.989 0.000
C32.9 Larynx, unspecified
0.011 0.989 0.000
C49.4 Connective and soft tissue of abdomen
0.011 0.989 0.000
C45.7 Mesothelioma of other sites
0.011 0.989 0.000
E78.8 Other disorders of lipoprotein metabolism
0.000 0.989 0.011
E80.2 Other porphyria
0.000 0.989 0.011
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.989 0.011
E80.5 Crigler-Najjar syndrome
0.000 0.989 0.011
E80.3 Defects of catalase and peroxydase
0.000 0.989 0.011
E80.1 Porphyria cutanea tarda
0.000 0.989 0.011
E80.0 Hereditary erythropoietic porphyria
0.000 0.989 0.011
C43.7 Malignant melanoma of lower limb, including hip
0.011 0.989 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.011 0.989 0.000
Chapter II Neoplasms
0.011 0.989 0.000
D46.4 Refractory anaemia, unspecified
0.011 0.989 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.011 0.989 0.000
Z48.0 Attention to surgical dressings and sutures
0.000 0.989 0.011
D37-D48 Neoplasms of uncertain or unknown behaviour
0.011 0.989 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.011 0.989 0.000
O47 False labour
0.011 0.989 0.000
C32.0 Glottis
0.010 0.989 0.000
E73.9 Lactose intolerance, unspecified
0.001 0.990 0.010
E85.9 Amyloidosis, unspecified
0.001 0.990 0.010
D46.7 Other myelodysplastic syndromes
0.010 0.990 0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.010 0.990 0.000
D46.5 Refractory anaemia with multi-lineage dysplasia
0.010 0.990 0.000
D46.3 Refractory anaemia with excess of blasts with transformation
0.010 0.990 0.000
D46.1 Refractory anaemia with sideroblasts
0.010 0.990 0.000
D46.0 Refractory anaemia without sideroblasts, so stated
0.010 0.990 0.000
C45.2 Mesothelioma of pericardium
0.010 0.990 0.000
C45.1 Mesothelioma of peritoneum
0.010 0.990 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.010 0.990 0.000
E78.3 Hyperchylomicronaemia
0.000 0.990 0.010
C64-C68 Malignant neoplasms of urinary tract
0.010 0.990 0.000
D38.0 Larynx
0.010 0.990 0.000
C65 Malignant neoplasm of renal pelvis
0.009 0.991 0.000
O47.0 False labour before 37 completed weeks of gestation
0.009 0.991 0.000
D38.1 Trachea, bronchus and lung
0.009 0.991 0.000
C32.8 Overlapping lesion of larynx
0.009 0.991 0.000
C32.3 Laryngeal cartilage
0.009 0.991 0.000
C32.2 Subglottis
0.009 0.991 0.000
D40.0 Prostate
0.009 0.991 0.000
E78.6 Lipoprotein deficiency
0.000 0.991 0.009
E78.4 Other hyperlipidaemia
0.000 0.991 0.009
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.009 0.991 0.000
C37 Malignant neoplasm of thymus
0.009 0.991 0.000
E78.1 Pure hyperglyceridaemia
0.000 0.991 0.009
Z45.0 Adjustment and management of cardiac pacemaker
0.000 0.991 0.009
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.009 0.991 0.000
T66-T78 Other and unspecified effects of external causes
0.009 0.991 0.000
Z95.0 Presence of cardiac pacemaker
0.000 0.991 0.009
E55.9 Vitamin D deficiency, unspecified
0.001 0.991 0.008
C46.9 Kaposi's sarcoma, unspecified
0.008 0.992 0.000
C46.8 Kaposi's sarcoma of multiple organs
0.008 0.992 0.000
C46.7 Kaposi's sarcoma of other sites
0.008 0.992 0.000
C46.3 Kaposi's sarcoma of lymph nodes
0.008 0.992 0.000
C46.2 Kaposi's sarcoma of palate
0.008 0.992 0.000
C46.1 Kaposi's sarcoma of soft tissue
0.008 0.992 0.000
C46.0 Kaposi's sarcoma of skin
0.008 0.992 0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.008 0.992 0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.008 0.992 0.000
C47.6 Peripheral nerves of trunk, unspecified
0.008 0.992 0.000
C47.5 Peripheral nerves of pelvis
0.008 0.992 0.000
C47.4 Peripheral nerves of abdomen
0.008 0.992 0.000
C47.3 Peripheral nerves of thorax
0.008 0.992 0.000
C47.2 Peripheral nerves of lower limb, including hip
0.008 0.992 0.000
C47.1 Peripheral nerves of upper limb, including shoulder
0.008 0.992 0.000
C47.0 Peripheral nerves of head, face and neck
0.008 0.992 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.008 0.992 0.000
E80.6 Other disorders of bilirubin metabolism
0.001 0.992 0.008
C67.1 Dome of bladder
0.008 0.992 0.000
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.992 0.008
C66 Malignant neoplasm of ureter
0.008 0.992 0.000
D40.1 Testis
0.008 0.992 0.000
D38.5 Other respiratory organs
0.008 0.992 0.000
C50-C50 Malignant neoplasm of breast
0.008 0.992 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.008 0.992 0.000
C31 Malignant neoplasm of accessory sinuses
0.008 0.992 0.000
C33 Malignant neoplasm of trachea
0.008 0.992 0.000
I89.0 Lymphoedema, not elsewhere classified
0.000 0.992 0.008
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.008 0.992 0.000
C67 Malignant neoplasm of bladder
0.008 0.992 0.000
Q27 Other congenital malformations of peripheral vascular system
0.008 0.992 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.008 0.992 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.008 0.992 0.000
D38.6 Respiratory organ, unspecified
0.008 0.992 0.000
D38.4 Thymus
0.008 0.992 0.000
D38.3 Mediastinum
0.008 0.992 0.000
D38.2 Pleura
0.008 0.992 0.000
O47.9 False labour, unspecified
0.008 0.992 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.008 0.992 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.008 0.992 0.000
C81.1 Nodular sclerosis
0.008 0.992 0.000
N95.1 Menopausal and female climacteric states
0.008 0.992 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.008 0.992 0.000
D44.6 Carotid body
0.008 0.992 0.000
Q23 Congenital malformations of aortic and mitral valves
0.008 0.992 0.000
C69 Malignant neoplasm of eye and adnexa
0.008 0.992 0.000
T66 Unspecified effects of radiation
0.008 0.992 0.000
Q23.1 Congenital insufficiency of aortic valve
0.007 0.992 0.000
D44.7 Aortic body and other paraganglia
0.007 0.992 0.000
Q27.3 Peripheral arteriovenous malformation
0.007 0.992 0.000
D40.9 Male genital organ, unspecified
0.007 0.993 0.000
D40.7 Other male genital organs
0.007 0.993 0.000
Q25 Congenital malformations of great arteries
0.007 0.993 0.000
D44.9 Endocrine gland, unspecified
0.007 0.993 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.007 0.993 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.007 0.993 0.000
C74 Malignant neoplasm of adrenal gland
0.007 0.993 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.007 0.993 0.000
D44.4 Craniopharyngeal duct
0.007 0.993 0.000
D48.6 Breast
0.007 0.993 0.000
C44.4 Skin of scalp and neck
0.007 0.993 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.007 0.993 0.000
Q27.8 Other specified congenital malformations of peripheral vascular system
0.007 0.993 0.000
D00-D09 In situ neoplasms
0.007 0.993 0.000
C45.0 Mesothelioma of pleura
0.007 0.993 0.000
C69.3 Choroid
0.007 0.993 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.993 0.007
D44.5 Pineal gland
0.007 0.993 0.000
D44.2 Parathyroid gland
0.007 0.993 0.000
Q28 Other congenital malformations of circulatory system
0.007 0.993 0.000
D05.1 Intraductal carcinoma in situ
0.007 0.993 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.007 0.993 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.006 0.993 0.000
C74.9 Adrenal gland, unspecified
0.007 0.993 0.000
C81 Hodgkin's disease
0.007 0.993 0.000
D44.1 Adrenal gland
0.006 0.993 0.000
T74 Maltreatment syndromes
0.006 0.993 0.000
T73 Effects of other deprivation
0.006 0.993 0.000
T70 Effects of air pressure and water pressure
0.006 0.993 0.000
T69 Other effects of reduced temperature
0.006 0.993 0.000
T67 Effects of heat and light
0.006 0.993 0.000
C69.0 Conjunctiva
0.006 0.994 0.000
D48.7 Other specified sites
0.006 0.994 0.000
D48.0 Bone and articular cartilage
0.006 0.994 0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified
0.006 0.994 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.006 0.994 0.000
D44.8 Pluriglandular involvement
0.006 0.994 0.000
Q24 Other congenital malformations of heart
0.006 0.994 0.000
C67.4 Posterior wall of bladder
0.006 0.994 0.000
Q23.0 Congenital stenosis of aortic valve
0.006 0.994 0.000
T68 Hypothermia
0.006 0.994 0.000
C67.8 Overlapping lesion of bladder
0.006 0.994 0.000
C69.9 Eye, unspecified
0.006 0.994 0.000
C40.0 Scapula and long bones of upper limb
0.006 0.994 0.000
C50.8 Overlapping lesion of breast
0.006 0.994 0.000
Q25.4 Other congenital malformations of aorta
0.006 0.994 0.000
Q25.1 Coarctation of aorta
0.006 0.994 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.